| Lung Non-Squamous Non-Small Cell Carcinoma investigated in trials for …INVESTIGATED_IN_TRIALSderived79 of 79show fewer |
|---|
| → investigated in trials for | Carboplatinsmall molecule 55 trials (21 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall_molecule 54 trials (17 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal_antibody 42 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 40 trials (11 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 34 trials (6 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 30 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 27 trials (15 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 27 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 20 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 14 trials (7 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinib Hydrochloridesmall molecule 10 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gefitinibsmall molecule 10 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Osimertinibsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal_antibody 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Onartuzumabmonoclonal antibody 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal_antibody 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Firmonertinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Icotinibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nintedanibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lorlatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pictilisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Poziotinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ramucirumabmonoclonal antibody 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sotorasibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zongertinibsmall_molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alpelisibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aumolertinibsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brigatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capmatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin OR Cisplatin 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatin/Paclitaxel Regimen 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cixutumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ensartinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 1 trials (1 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Immune Checkpoint Inhibitor 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lazertinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Luminespibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegargiminaseother 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rucaparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Serplulimabmonoclonal_antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teprotumumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tremelimumabmonoclonal antibody 1 trials (0 active) · roll-up of the cancer and its descendants | — | — | Lung Non-Squamous Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |